Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

CNBC

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

EconomyDaily Composite
ShareXFacebook

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

C

Source

CNBC

Read full article at CNBC

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement